The main roles of the radiochemistry core at AMC are to support;
Existing non-commercially available radiopharmaceuticals as research tools in clinical research.
Development of radiopharmaceuticals for clinically relevant disorders.
Synthesis of reagents for in vitro investigations or drug screening.
Please see the Radiochemistry rates for a list of currently available radionuclides.
Yubin Miao, Ph.D.
Director of Radiopharmaceutical Science